Health
FDA Approves New Opioid Overdose Nasal Spray
The FDA has approved a third over-the-counter opioid overdose nasal spray, which could save lives and reduce costs. The new product is expected to be widely available soon.
Coverage timeline — 1 article
The Hill
The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the agency said could save lives and reduce costs. The agency approved another Rextovy, a 4 milligram naloxone nasal spray for the emergency treatment of opioid overdose. FDA
2026-06-16 21:52 UTC